Skip to Main Content

Author Details

Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
2011
63
14
PMIDPaper TitleJournal TitlePublished Year
37812042TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.Prostate2024
37558543Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.Eur Urol Oncol2024
37748118Metastasis-Directed Therapy: A Moving Target Advancing Progress Forward.J Clin Oncol2024
37945142Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma.Surg Oncol Clin N Am2024
36367998Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.J Clin Oncol2023
37504333Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research.Curr Oncol2023
37566929Cell-free DNA sequencing sheds additional insights on BRCA-altered metastatic castration-resistant prostate cancer.EBioMedicine2023
37025121A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives.AME Med J2023
37024391Locally Advanced Lung Cancer.Hematol Oncol Clin North Am2023
37017928Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?Curr Urol Rep2023
37182986A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers.Surg Oncol Clin N Am2023
37444636Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach.Cancers (Basel)2023
37173210Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.Eur Urol2023
36691564Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer.Clin Transl Radiat Oncol2023
36708787WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2023
36821803Waiting for Big Changes in Limited-Stage Small-Cell Lung Cancer: For Now, More of the Same.J Clin Oncol2023
35058322The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging.J Nucl Med2022
35657158Genomic biomarkers to guide precision radiotherapy in prostate cancer.Prostate2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
36244393From Idea to Clinical Practice: A Brief History of Oligometastatic Disease.Int J Radiat Oncol Biol Phys2022
36244387Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?Int J Radiat Oncol Biol Phys2022
36388654Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review.J Gastrointest Oncol2022
35014708Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?Prostate2022
35013522Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.Prostate Cancer Prostatic Dis2022
32536574Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer.Eur Urol Oncol2021
34952610Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.Radiat Oncol2021
35070437Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report.J Gastrointest Oncol2021
35070387Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy.J Gastrointest Oncol2021
34801437Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review.Eur Urol Oncol2021
34044095Can Sex and Seniority Predict the Quality of a Journal Reviewer's Manuscript Critique?Int J Radiat Oncol Biol Phys2021
34273331In Reply to Onal et al.Int J Radiat Oncol Biol Phys2021
34263627Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer.Ann Palliat Med2021
34090651Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer.Semin Radiat Oncol2021
33419682The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.Eur Urol2021
32798608Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2021
32487038A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).BMC Cancer2020
31977391Radiotherapy in the Management of Metastatic Hormone-Sensitive Prostate Cancer: What Is the Standard of Care?Cancer J2020
32815993Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer-Not All That Glitters Is Gold-Reply.JAMA Oncol2020
32642155Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer.J Thorac Dis2020
32215577Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol2020
32205538Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.Cancer J2020
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
30268657Is Androgen Deprivation Therapy "Another Deficient Therapy" for Gleason Score 9-10 Prostate Cancer?Eur Urol2019
31661149Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How?Oncology (Williston Park)2019
30191396Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.World J Urol2019
30144583Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.Pract Radiat Oncol2019
31183202Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity.J Gastrointest Oncol2019
31196032A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).BMC Cancer2019
31419509Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.Int J Radiat Oncol Biol Phys2019
31019945Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer.Ann Transl Med2019
  • 1 - 50 of 63

Recommended Authors

Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 27
Robert T Dess
University of Michigan ann arbor
Career Start Year 2016
Number of shared co-authors 33
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 9
William C Jackson
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 30
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 6
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 31
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 0
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 30
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 20
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 7
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 10
Michael Xiang
University of California los angeles
Career Start Year 2007
Number of shared co-authors 26
Arun A Azad
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 4
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 25
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 5
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 14
Niven Mehra
Radboud university medical center
Career Start Year 2004
Number of shared co-authors 15
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 22
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 12
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 8
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 23
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 6
Evan Y Yu
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 21
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 3
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 25
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 11
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 31
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 35

Collaborators

Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 30
Ryan Phillips
Johns Hopkins University
Co-authored papers 16
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 16
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 15
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 12
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 12
Curtiland Deville
Johns Hopkins University
Co-authored papers 10
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 10
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 10
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 9
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 9
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Co-authored papers 8
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 8
Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 8
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 7
Ashley E Ross
Northwestern University
Co-authored papers 5
Mark C Markowski
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 5
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
Bradley J Stish
Mayo Clinic
Co-authored papers 4
Amar U Kishan
University of California los angeles
Co-authored papers 4
Neil B Desai
University of Texas Southwestern Medical Center
Co-authored papers 3
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Elai Davicioni
Veracyte Inc.
Co-authored papers 3
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 3
Alexander W Wyatt
University of British Columbia
Co-authored papers 3
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 2
Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Elisabeth I Heath
Karmanos Cancer Center, Wayne State University
Co-authored papers 2
Release 1.2